Epic Sciences Garners $30,000,000 Series C Funding Round

  • Feed Type
  • Date
    7/30/2014
  • Company Name
    Epic Sciences
  • Mailing Address
    9381 Judicial Drive La Jolla, CA 92121 USA
  • Company Description
    We develop new, highly sensitive diagnostic tests that identify and molecularly characterize circulating tumor cells (CTCs) in the blood to provide a better way to detect cancer and personalize and monitor treatments.
  • Website
    http://www.epicsciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    With the proceeds of the financing, Epic will commercialize its circulating rare cell analysis platform with special focus on developing products and services to detect circulating tumor cells (CTC) in cancer.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy